日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.

食管鳞状细胞癌中转铁蛋白受体的过度表达提示预后不良和潜在治疗。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70195
Ikenaga Naoki, Takahashi Tsuyoshi, Tanaka Koji, Serada Satoshi, Fujimoto Minoru, Momose Kota, Yamashita Kotaro, Makino Tomoki, Saito Takuro, Yamamoto Kazuyoshi, Kurokawa Yukinori, Nakajima Kiyokazu, Fujii Tomomi, Morii Eiichi, Naka Tetsuji, Eguchi Hidetoshi, Doki Yuichiro
细胞生物学
发表日期：2026
文献求助 收藏

Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells

靶向Yes相关蛋白以克服胃肠道间质瘤耐药持续细胞的伊马替尼耐药性

期刊:Gastric Cancer
影响因子:5.1
doi:10.1007/s10120-025-01657-z
Yokouchi, Takashi; Takahashi, Tsuyoshi; Nishida, Toshirou; Tanaka, Koji; Kurokawa, Yukinori; Yamamoto, Kazuyoshi; Saito, Takuro; Hagi, Takaomi; Momose, Kota; Yamashita, Kotaro; Makino, Tomoki; Kawai, Kunihiko; Serada, Satoshi; Fujimoto, Minoru; Hirota, Seiichi; Nakajima, Kiyokazu; Naka, Tetsuji; Eguchi, Hidetoshi; Doki, Yuichiro
细胞生物学
发表日期：2025
文献求助 收藏

CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial

在白俄罗斯开展的 CD19 CAR T 细胞疗法 BY19 用于治疗复发或难治性 B 细胞肿瘤的儿童和成人患者：I 期试验

期刊:Molecular Therapy Oncology
影响因子:4.5
doi:10.1016/j.omton.2025.201081
Mikalai Katsin,Dmitri Dormeshkin,Alexandr Migas,Olga Karas,Tatsiana Shman,Yuliya Serada,Yauheniya Khalankova,Hanna Klych,Dzmitry Lutskovich,Alena Lukoika,Alexander Meleshko
细胞生物学
肿瘤
CD19
发表日期：2025
文献求助 收藏

Glypican-1-targeted antibody-drug conjugate inhibits the growth of glypican-1-positive glioblastoma

靶向 Glypican-1 的抗体药物偶联物可抑制 Glypican-1 阳性胶质母细胞瘤的生长

期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2024.100982
Uchida, Shun; Serada, Satoshi; Suzuki, Yuji; Funajima, Eiji; Kitakami, Kei; Dobashi, Kazumasa; Tamatani, Satomi; Sato, Yuichi; Beppu, Takaaki; Ogasawara, Kuniaki; Naka, Testuji
细胞生物学
发表日期：2024
文献求助 收藏

Case report: Rapid resolution of grade IV ICANS after first line intrathecal chemotherapy with methotrexate, cytarabine and dexamethasone

病例报告：甲氨蝶呤、阿糖胞苷和地塞米松一线鞘内化疗后，IV级ICANS迅速消退

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1380451
Katsin, Mikalai; Shman, Tatsiana; Migas, Alexandr; Lutskovich, Dzmitry; Serada, Yuliya; Khalankova, Yauheniya; Kostina, Yuliya; Dubovik, Simon
发表日期：2024
文献求助 收藏

Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.

一种新的生殖系 STAT3 功能获得性突变会导致自身免疫性疾病和严重的生长发育障碍。

期刊:Journal of Allergy and Clinical Immunology Global
影响因子:
doi:10.1016/j.jacig.2024.100312
Saito Koji, Fujimoto Minoru, Funajima Eiji, Serada Satoshi, Ohkawara Tomoharu, Ishihara Masayuki, Yamada Mamiko, Suzuki Hisato, Miya Fuyuki, Kosaki Kenjiro, Fujieda Mikiya, Naka Tetsuji
JAK/STAT
自身免疫性疾病
STAT3
发育与干细胞
免疫/内分泌
发表日期：2024
文献求助 收藏

Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma

使用 89Zr 或 211At 标记的抗磷脂酰肌醇蛋白聚糖-1 抗体进行免疫 PET 和靶向 α 疗法：一种治疗胰腺导管腺癌的诊断方法

期刊:Journal of Nuclear Medicine
影响因子:9.1
doi:10.2967/jnumed.123.266313
Tadashi Watabe, Kazuya Kabayama, Sadahiro Naka, Ryuku Yamamoto, Kazuko Kaneda, Satoshi Serada, Kazuhiro Ooe, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Kenta Kurimoto, Takanori Kobayashi, Eku Shimosegawa, Noriyuki Tomiyama, Koichi Fukase, Tetsuji Naka
代谢
肿瘤
胰腺癌
发表日期：2023
文献求助 收藏

Protein-to-lipid ratio uniquely changes the rate of lysozyme aggregation but does not significantly alter toxicity of mature protein aggregates

蛋白质与脂质的比率独特地改变了溶菌酶聚集的速率，但并没有显着改变成熟蛋白质聚集体的毒性

期刊:Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids
影响因子:3.9
doi:10.1016/j.bbalip.2023.159305
Kiryl Zhaliazka, Valeryia Serada, Mikhail Matveyenka, Stanislav Rizevsky, Dmitry Kurouski
微生物学
发表日期：2023
文献求助 收藏

Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer

脂肪分解刺激脂蛋白受体靶向抗体-药物偶联物对上皮性卵巢癌表现出强大的抗肿瘤活性

期刊:Neoplasia
影响因子:
doi:10.1016/j.neo.2022.100853
Mizuki Kanda, Satoshi Serada, Kosuke Hiramatsu, Masashi Funauchi, Kengo Obata, Satoshi Nakagawa, Tomoharu Ohkawara, Okinori Murata, Minoru Fujimoto, Fumiko Chiwaki, Hiroki Sasaki, Yutaka Ueda, Tadashi Kimura, Tetsuji Naka
肿瘤
卵巢癌
发表日期：2023
文献求助 收藏

Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer

抗脂解刺激脂蛋白受体单克隆抗体作为子宫内膜癌的新型治疗剂

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09789-6
Yoshikazu Nagase, Kosuke Hiramatsu, Masashi Funauchi, Mayu Shiomi, Tatsuo Masuda, Mamoru Kakuda, Satoshi Nakagawa, Ai Miyoshi, Shinya Matsuzaki, Eiji Kobayashi, Toshihiro Kimura, Satoshi Serada, Yutaka Ueda, Tetsuji Naka, Tadashi Kimura
肿瘤
子宫内膜癌
IHC
发表日期：2022
文献求助 收藏